Document Detail


Maternal serum C-reactive protein concentration early in pregnancy and subsequent pregnancy loss.
MedLine Citation:
PMID:  16118717     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The purpose of this study was to determine the relationship between maternal inflammation and first or second trimester pregnancy loss. A nested case-control analysis was performed among the cohort enrolled in the Oral Conditions and Pregnancy study. We compared maternal serum C-reactive protein concentration between women with a pregnancy loss at < 21 weeks gestation to control women without gestational diabetes or preeclampsia who delivered at term. Participants were 2:1 frequency matched to cases by maternal age, race, and prior preterm birth. Median concentration of serum C-reactive protein between cases and controls was compared using Wilcoxon rank sum test. The potential effects of maternal smoking, gestational age at blood draw, and insurance status were evaluated and an adjusted odds ratio (95% confidence interval) for pregnancy loss was calculated using multivariable logistic regression. Among 1224 participants, 102 (9.8%) experienced pregnancy loss and 44 had complete information available. Median serum C-reactive protein concentration was significantly higher in controls compared with all cases (3.2 versus 0.5 microg/mL; p < 0.001). However, when stratified by gestational age at the time of the loss, median serum C-reactive protein level among controls was similar to those with a loss at less than 12 weeks (3.2 versus 2.0 microg/mL) but significantly higher compared with those whose loss occurred at greater than 12 weeks gestation (3.2 versus 0.5 microg/mL; p < 0.05). After adjusting for maternal smoking, gestational age at blood draw, and insurance status, women whose serum C-reactive protein level was greater than the 75% percentile had a decreased odds ratio for pregnancy loss (0.20; 95% confidence interval, 0.06 to 0.65). Pregnancy loss is not associated with increased systemic inflammation as measured by maternal serum C-reactive protein. Future study should be directed at determining the role of maternal inflammation during early pregnancy development and placentation.
Authors:
Kim A Boggess; Susan Lieff; Amy P Murtha; Kevin Moss; Heather Jared; James Beck; Steven Offenbacher
Related Documents :
3964607 - Serum protein binding of diazepam and propranolol in the feto-maternal unit from early ...
6384247 - Somatomedin levels in pregnancy: longitudinal study in healthy subjects and patients wi...
8677767 - Pregnancy related changes in some cardiovascular risk factors.
17203787 - Tissue polypeptide specific antigen and soluble fas during normal pregnancy and early l...
477317 - Microsurgical tubal anastomosis in the rabbit following three types of sterilisation pr...
7512267 - The relationship of uterine and umbilical doppler resistance to fetal and placental pro...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  American journal of perinatology     Volume:  22     ISSN:  0735-1631     ISO Abbreviation:  Am J Perinatol     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-08-24     Completed Date:  2005-12-14     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8405212     Medline TA:  Am J Perinatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  299-304     Citation Subset:  IM    
Affiliation:
Division of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, University of North Carolina, Chapel Hill, North Carolina 27599, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortion, Spontaneous / epidemiology,  metabolism*
Adult
Biological Markers / blood
C-Reactive Protein / metabolism*
Case-Control Studies
Cohort Studies
Female
Gestational Age
Humans
Inflammation / blood
Logistic Models
Multivariate Analysis
North Carolina / epidemiology
Odds Ratio
Pregnancy
Pregnancy Outcome
Pregnancy Trimester, First / metabolism*
Pregnancy Trimester, Second / metabolism*
Statistics, Nonparametric
Grant Support
ID/Acronym/Agency:
K12-HD-01441/HD/NICHD NIH HHS; R01-DE-012453/DE/NIDCR NIH HHS; RR00046/RR/NCRR NIH HHS
Chemical
Reg. No./Substance:
0/Biological Markers; 9007-41-4/C-Reactive Protein

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Preterm premature rupture of membranes: perspectives surrounding controversies in management.
Next Document:  Insulin-like growth factor binding protein-1 detection in preterm labor: evaluation of a bedside tes...